Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07375225 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy

Study acronym: ALINET
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Evaluation of adherence, persistence and efficacy of treatment with alirocumab 300 mg in a real-life Italian population.
Trial Details
NCT Number NCT07375225
Lead Sponsor Federico II University
Conditions
(from sponsor)		 Hypercholesterolaemia
Related terms Hypercholesterolemia
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov